Press Releases

The Wistar Institute and partners at the Perelman School of Medicine at the University of Pennsylvania, Inovio Pharmaceuticals, and GeneOne Life Science were recognized among the Top 10 Clinical Research Achievement Awards by the Clinical Research Forum for their ground-breaking phase 1 DNA-based Zika vaccine research – the first trial of a Zika vaccine in humans, which proved safe and effective. These study results were published in October in the New England Journal of Medicine.

Major investment by CEPI to advance vaccine development and manufacturing on two of CEPI’s highest priority diseases.

Collaborative effort sets the record straight on the use of CD32 as a biomarker to measure HIV reservoirs.

ISOMA is helping identify new treatment solutions for glioblastoma patients

New study shows that antibodies induce accumulation of myeloid suppressor cells.